Update on pharmacotherapy for ocular surface squamous neoplasia | Eye and Vision | Full Text
Elsevier – Drug Monograph │Fluorouracil, 5-FU
Topical Chemotherapy for Ocular Surface Squamous Neoplasia - American Academy of Ophthalmology
Strategies to prolong the residence time of drug delivery systems on ocular surface - ScienceDirect
Molecules | Free Full-Text | Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies
Nano drug delivery system in Ophthalmology | IJN
Molecules | Free Full-Text | Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies
Update on pharmacotherapy for ocular surface squamous neoplasia | Eye and Vision | Full Text
Topical fluorouracil after surgery for ocular surface squamous neoplasia in Kenya: a randomised, double-blind, placebo-controlled trial - The Lancet Global Health
Ocular prodrugs: Attributes and challenges - ScienceDirect
Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study
Cureus | Efficacy of 5-Fluorouracil in the Treatment of Pterygium | Article
Nano-based eye drop: Topical and noninvasive therapy for ocular diseases - ScienceDirect
Recent developments of temperature‐responsive polymers for ophthalmic applications - Ow - 2022 - Journal of Polymer Science - Wiley Online Library
Intra-lesional 5 fluorouracil for the management of recurrent pterygium | Eye
Topical fluorouracil after surgery for ocular surface squamous neoplasia in Kenya: a randomised, double-blind, placebo-controlled trial - The Lancet Global Health
PDF) 5-Fluorouracil for the treatment of intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva, and cornea